Profile
SpringTide Ventures is a venture capital firm based in Cambridge, Massachusetts, founded in 2018. The firm is led by a team of six professionals who focus on supporting health-tech founders. SpringTide Ventures differentiates itself by embedding clinical operators and offering direct access to policymakers and system leaders, particularly for underserved patient populations.
The firm primarily invests in the healthcare sector, with a focus on health, medtech, biotech, AI, and data services. They typically invest in early-stage companies, including pre-seed, seed, and Series A rounds, with check sizes ranging from $500K to $5M. SpringTide Ventures manages two funds: SpringTide Ventures I with $19 million AUM launched in 2019, and SpringTide Ventures II with $65 million AUM launched in 2024.
Notable investments include Wellsheet - clinical intelligence platform, Great Expectations - data quality layer for healthcare, Paterna Biosciences - reproductive medicine innovation, OpenLoop - telehealth infrastructure, and Tenovi - remote patient monitoring solutions.
Industry
SpringTide Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
SpringTide Ventures I
|
Venture Capital (VC)
|
Biotechnology
Digital
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$19 M
|
December 2019
|
|
SpringTide Ventures II
|
Venture Capital (VC)
|
Life Sciences
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$65 M
|
April 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.